Careers  |  Sign In  |  Register

Latest in Hospitalist

Reuters Health • The Doctor's Channel Daily Newscast

Real-world cardiac resynchronization outcomes poorer than in clinical trials

NEW YORK (Reuters Health) - The benefits of cardiac resynchronization therapy (CRT) are less pronounced for typical “real-world” patients -- particularly those with right bundle-branch block -- than previously recognized, report investigators at the University of Virginia Health System,...

Reuters Health • The Doctor's Channel Daily Newscast

Ceftaroline may be better than ceftriaxone for community-acquired pneumonia

NEW YORK (Reuters Health) – Cure rates are similar when patients hospitalized with community-acquired pneumonia are treated with ceftaroline or ceftriaxone -- but ceftaroline may have the edge, investigators report in the December 15th issue of Clinical Infectious Diseases. Dr. Thomas M. File of...

Reuters Health • The Doctor's Channel Daily Newscast

Blunt advice: Don’t use recombinant factor VIIa for non-hemophiliac bleeding

NEW YORK (Reuters Health) – The off-label use of recombinant factor VIIa for hemostasis in patients without hemophilia confers only modest benefits but may increase the risk of thromboembolic events, according to the results of a meta-analysis published online November 15 in the Canadian Medical...